K.E. Near et al. / Journal of Organometallic Chemistry 696 (2011) 81e86
83
anhydrous MgSO4, and the solvent was removed in vacuo to yield
a white solid (2.26 g, 7.41 mmol, 73.4%). The product can be purified
by recrystallization from 6:1 hexanes/CH2Cl2.
5.52 mmol). The resulting crude solid was purified by flash column
chromatography (40% EtOAc/60% hexanes) and recrystallized from
6:1 hexanes/CH2Cl2 to yield a white solid (0.784 g, 2.35 mmol,
44.0%).
M.p. 60e62 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 7.61 (d, J ¼ 6.5 Hz,
2H, eSO2(C6H2H2)), 7.20 (m, 5H, Ar), 7.00 (d, J ¼ 5.6 Hz,
2H, eSO2(C6H2H2)), 3.65 (m, 1H, eCHHOH), 3.55 (m, 1H,
eCHHOH), 3.46 (m, 1H, eCH), 2.80 (dd, J1 ¼13.8 Hz, J2 ¼ 7.1 Hz,
1H, eCHHAr), 2.71 (dd, J1 ¼13.8 Hz, J2 ¼ 7.2 Hz, 1H, eCHHAr), 2.43
M.p. 130e132 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 7.35
(d, J ¼ 8.3 Hz, 2H, eSO2(C6H2H2)), 7.08 (m, 5H, Ar), 6.93
(d, J ¼ 6.7 Hz, 2H, eSO2(C6H2H2)), 4.54 (d, J ¼ 7.9 Hz, 1H, eNH), 3.46
(m, 1H, eCH), 3.01 (dd, J1 ¼14.2 Hz, J2 ¼ 4.2 Hz, 1H, eCHHAr), 2.55
(s, 1H, eOH), 2.43 (dd, J1 ¼14.2, J2 ¼ 9.6 Hz, 1H, eCHHAr), 2.40 (s,
3H, eArCH3), 1.28 (s, 3H, eCH3), 1.26 (s, 3H, eCH3). 13C NMR
(s, 3H, eArCH3). 13C NMR (100 MHz, CDCl3):
d
¼ 143.6, 137.1, 137.0,
129.9, 129.4, 128.9, 127.3, 126.9, 64.2, 56.9, 38.0, 21.8.
23.6
[
a]
¼ ꢀ37.8ꢁ (c ¼ 0.0520 g/mL, EtOAc). Anal. Calcd for
(100 MHz, CDCl3):
126.6, 72.9, 64.6, 37.8, 27.9, 25.7, 21.6. [
mL, EtOAc). Anal. Calcd for C18H23O3NS: C, 64.84; H, 6.95; N, 4.20.
Found: C, 63.85; H, 6.85; N, 4.24. HRMS (FABþ) Calcd for
C18H24O3NS (MHþ): 334.1477, found: 334.1485.
d
¼ 143.0, 137.6, 137.1, 129.6, 129.2, 128.7, 127.0,
D
24.5
C16H19NO3S: C, 62.93; H, 6.27; N, 4.59. Found: C, 62.70; H, 6.08; N,
4.74. HRMS (ESþ) Calcd for C16H20NO3S (MHþ): 306.1164, found:
306.1158.
a]
¼ ꢀ60.4ꢁ (c ¼ 0.036 g/
D
2.3. Synthesis of sulfonamide 6b
2.6. Synthesis of methylated sulfonamide 6e
Ligand 6b was prepared according to procedure 1 starting from
(S)-(ꢀ)-2-amino-3-phenyl-1-propanol (2.09 g, 13.8 mmol), NEt3
(4.30 mL, 30.9 mmol), DMAP and 4-(trifluoromethyl)benzene
sulfonyl chloride (3.43 g, 14.0 mmol). The resulting crude solid was
purified by flash column chromatography (30% EtOAc/70% hexanes)
and then recrystallized from 6:1 hexanes/CH2Cl2 to yield a white
solid (2.86 g, 7.95 mmol, 57.6%).
Ligand 6e was prepared according to procedure 1 starting from
(S)-3-amino-2-methyl-4-phenyl-2-butanol (0.716 g, 3.99 mmol),
NEt3 (1.14 mL, 8.18 mmol), DMAP and 4-(trifluoromethyl)benzene
sulfonyl chloride (0.921 g, 4.10 mmol). The resulting crude solid
was purified by flash column chromatography (35% EtOAc/65%
hexanes) and recrystallized from 6:1 hexanes/CH2Cl2 to yield
a white solid (0.395 g, 1.02 mmol, 25.6%).
M.p. 137e139 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 7.71 (d,
J ¼ 8.3 Hz, 2H, eSO2(C6H2H2)), 7.61 (d, J ¼ 8.5 Hz, 2H,
eSO2(C6H2H2)), 7.15 (m, 3H, Ar), 6.96 (d, J ¼ 9.1 Hz, 2H, Ar), 4.99
(d, J ¼ 7.3 Hz, 1H, eNH), 3.74 (m, 1H, eCHHOH), 3.68 (m, 1H,
eCHHOH), 3.51 (m, 1H, eCH), 2.87 (dd, J1 ¼13.9 Hz, J2 ¼ 5.8, 1H,
eCHHAr), 2.69 (dd, J1 ¼13.9 Hz, J2 ¼ 8.7, 1H, eCHHAr), 2.18 (t,
M.p. 122e124 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 7.47
(s, 4H, eSO2(C6H4)), 7.07 (t, J ¼ 7.2 Hz, 1H, Ar), 7.00 (t, J ¼ 7.5 Hz, 2H,
Ar), 6.88 (d, J ¼ 7.1 Hz, 2H, Ar), 4.73 (d, J ¼ 8.5 Hz, 1H, eNH), 3.55 (m,
1H, eCH), 3.05 (dd, J1 ¼14.2 Hz, J2 ¼ 3.3 Hz, 1H, eCHHAr), 2.41 (dd,
J1 ¼14.2, J2 ¼ 8.2 Hz, 1H, eCHHAr), 2.28 (s, 1H, eOH), 1.40 (s, 3H,
J ¼ 5.4 Hz, 1H, eOH). 13C NMR (100 MHz, CDCl3):
d
¼ 143.7, 137.0,
eCH3), 1.38 (s, 3H, eCH3). 13C NMR (100 MHz, CDCl3):
d
¼ 144.4,
2
2
134.7 (q, JCF ¼ 33.0 Hz), 129.3, 129.1, 127.7, 127.3, 126.5 (q,
137.9, 133.8 (q, JCF ¼ 33.3 Hz), 129.5, 128.9, 127.3, 127.2, 126.3 (m),
23.5
3JCF ¼ 3.7 Hz), 123.6 (q, 1JCF ¼ 272.7 Hz), 65.2, 57.7, 38.3.
123.7 (q, 1JCF ¼ 272.5 Hz), 73.3, 65.8, 37.6, 28.4, 26.5. [
a
]
¼ ꢀ66.8ꢁ
D
24.1
[
a]
¼ ꢀ44.4ꢁ (c ¼ 0.051 g/mL, EtOAc). Anal. Calcd for
(c ¼ 0.030 g/mL, EtOAc). Anal. Calcd for C18H20NSO3F3: C, 55.80; H,
5.20; N, 3.62. Found: C, 55.43; H, 5.04; N, 3.70. HRMS (FABþ) Calcd
for C18H21NSO3F3 (MHþ): 388.1194, found: 388.1177.
D
C16H16F3O3NS: C, 53.48; H, 4.49; N, 3.90. Found: C, 53.47; H, 4.31; N,
3.90. HRMS (FABþ) Calcd for C16H17F3O3NS (MHþ): 360.0881,
found: 360.0879.
2.7. Synthesis of methylated sulfonamide 6f
2.4. Synthesis of sulfonamide 6c
Ligand 6f was prepared according to procedure 1 starting from
(S)-3-amino-2-methyl-4-phenyl-2-butanol (0.696 g, 3.88 mmol),
NEt3 (1.20 mL, 11.9 mmol), DMAP and 3,5-bis-(trifluoromethyl)
benzenesulfonyl chloride (1.16 g, 3.70 mmol). The resulting crude
solid was purified by flash column chromatography (20% EtOAc/
80% hexanes) and recrystallized from 6:1 hexanes/CH2Cl2 to yield
a white solid (0.346 g, 0.777 mmol, 21.0%).
Ligand 6c was prepared according to procedure 1 starting from
(S)-(ꢀ)-2-amino-3-phenyl-1-propanol (0.755 g, 5.00 mmol), NEt3
(1.50 mL, 10.8 mmol), DMAP and 3,5-bis-(trifluoromethyl)benzene
sulfonyl chloride (1.61 g, 5.15 mmol). The resulting crude solid was
purified by flash column chromatography (30% EtOAc/70% hexanes)
and recrystallized from 6:1 hexanes/CH2Cl2 to yield a white solid
(1.00 g, 2.34 mmol, 46.8%).
M.p. 213e216 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 7.86
M.p. 124e125 ꢁC. 1H NMR (400 MHz, CDCl3):
d
¼ 8.07 (s, 2H,
(s, 2H, eSO2(C6H2H)), 7.85 (s, 1H, eSO2(C6H2H)), 6.89 (m, Ar), 4.94
(d, J ¼ 9.1 Hz, 1H, eNH), 3.62 (m, 1H, eCH), 3.06 (dd, J1 ¼14.1 Hz,
J2 ¼ 3.2 Hz, 1H, eCHHAr), 2.46 (dd, J1 ¼14.1, J2 ¼ 4.4 Hz, 1H,
eCHHAr), 1.96 (s, 1H, eOH), 1.46 (s, 3H, eCH3), 1.42 (s, 3H, eCH3).
eSO2(C6H2H)), 7.97 (s, 1H, eSO2(C6H2H)), 7.08 (m, 3H, Ar), 6.94 (m,
2H, Ar), 4.92 (d, J ¼ 7.3 Hz, 1H, eNH), 3.80 (m, 1H, eCHHOH), 3.72
(m, 1H, eCHHOH), 3.61 (m, 1H, eCH), 2.91 (dd, J1 ¼14.0 Hz,
J2 ¼ 5.5 Hz, 1H, eCHHAr), 2.69 (dd, J1 ¼14.0 Hz, J2 ¼ 9.1 Hz, 1H,
13C NMR (100 MHz, CDCl3):
d
¼ 144.1, 137.6, 132.7 (q, 2JCF ¼ 34.1 Hz),
1
eCHHAr), 1.92 (t, J ¼ 5.3 Hz, 1H, eOH). 13C NMR (100 MHz, CDCl3):
129.3, 128.8, 127.2, 127.1 (m), 126.0 (m), 122.8 (q, JCF ¼ 273.4 Hz),
2
23.8
d
¼ 143.3, 136.7, 133.1 (q, JCF ¼ 34.3 Hz), 129.2, 129.0, 127.5, 127.4
73.3, 65.9, 37.1, 28.7, 26.9. [
a]
¼ ꢀ54.5ꢁ (c ¼ 0.026 g/mL, EtOAc).
D
1
(m), 126.4 (m), 125.5 (q, JCF ¼ 273.4 Hz), 65.4, 58.1, 38.3.
Anal. Calcd for C19H19NSO3F6: C, 50.11; H, 4.21; N, 3.08. Found: C,
50.03; H, 3.52; N, 3.07. HRMS (FABþ) Calcd for C19H20NO3F6S
(MHþ): 456.1068, found: 456.1060.
24.5
[
a
]
¼ ꢀ40.7ꢁ (c ¼ 0.038 g/mL, EtOAc). Anal. Calcd for
D
C17H15NSO3F6: C, 47.78; H, 3.54; N, 3.28. Found: C, 47.43; H, 3.27; N,
3.27. HRMS (FABþ) Calcd for C17H16NSO3F6 (MHþ): 428.0755,
found: 428.0770.
2.8. Procedure 2, hydroamination with Ti(NMe2)4
2.5. Synthesis of methylated sulfonamide 6d
Sulfonamide ligand (75
m
L
of
L of a 0.0375 M solution in C6D6,
mol), 6-methyl-hepta-4,5-dienylamine (50 L of a 1.5 M
mol, 20 equiv), and C6D6 (175 L) were
combined in a J. Young NMR tube in the glovebox to make a 5 mol%
a 0.05 M solution in C6D6,
3.75
3.75
m
m
mol), Ti(NMe2)4 (100 m
Ligand 6d was prepared according to procedure 1 starting from
(S)-3-amino-2-methyl-4-phenyl-2-butanol (0.957 g, 5.34 mmol),
NEt3 (1.75 mL, 12.6 mmol), DMAP and p-tosyl chloride (1.05 g,
m
solution in C6D6, 75
m
m